HCD Event: Building China, Japan and Asia for European Life Science Companies

China and Japan are the second and third largest pharmaceutical markets globally, and the major markets in Asia is equivalent to that of Europe.  

In this event, you will learn about:

•  How should pharma (and medtech) companies think about their expansion to this important and dynamic region? 
• Where are the major opportunities? Pitfalls to avoid?
•  latest thinking around accelerated market entry options into these distinct markets for those with innovative therapies.

Brought to our Basel HCD community by Helen Chen - Global Sector Co-Head, Healthcare and Life Sciences, Greater China Managing Partner at L.E.K. Consulting.

This event is hosted by Slate Mountains Capital, and is happening face to face in ZURICH.